Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Depression: Depression & Related Conditions
Basic Information
Introduction and Types of Depressive DisordersRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
Facebook Posts May Hint at DepressionDo Dimmer Days in Pregnancy Raise Postpartum Depression Risk?Depression Strikes Nearly 1 in 5 Young Adults With Autism: StudyNew Dads Can Get the Baby Blues, TooHealth Tip: Help a New Mom With Postpartum DepressionCould a Blood Test Help Spot Severe Depression?Treating Depression May Prevent Repeat Heart AttackSupportive Managers Key When a Worker Is DepressedIs Depression During Pregnancy on the Rise?Know the Signs of Postpartum DepressionAre Your Meds Making You Depressed?Depression, Money Woes Higher in Heart Patients With Job LossSnubbed on Social Media? Your Depression Risk May RiseNever Ignore DepressionStudy Affirms What Many Know: Antidepressants May Lead to Weight GainECT Effective for Treatment-Resistant DepressionRates of Major Depression Up Among U.S. Insured, Esp. YouthResistance Exercise May Reduce Depressive Symptoms in AdultsDepression Striking More Young People Than EverDepression May Dampen MemoryCould Mom-to-Be's Antidepressants Have an Upside for Baby's Brain?Exercise Your Blues AwayGrip Strength Indicative of Cognition in Major DepressionKetamine Nasal Spray Shows Promise Against Depression, SuicideTelltale Clues That Your Child Is DepressedPrenatal Exposure to SSRI Tied to Fetal Brain DevelopmentDepressive Symptoms Tied to Diabetes Self-ManagementAbandoning Your Workouts May Bring on the BluesMany Grad Students Struggle With Anxiety, DepressionRelapse in Major Depression Linked to Brain Cortical ChangesIL-6 Levels Predict Response to ECT in Depressive Disorder1 in 20 Younger Women Suffers Major DepressionHeart-Healthy 'DASH' Diet May Also Help Lower Depression RiskGuidelines Updated for Managing and ID'ing Adolescent Depression21 Reviewed Antidepressants Top Placebo for Major DepressionAntidepressants Do Work, Some Better Than Others: StudyTreatment Initiation for Depression Low in Primary CareDuring 2013 to 2016, 8.1 Percent of U.S. Adults Had DepressionDepression Common in U.S., Women Hit HardestNo Proof At-Home 'Cranial Stimulation' Eases DepressionAcne Linked to Increased Risk of Major Depressive DisorderMany With Depression Delay, Avoid TreatmentPostnatal Depression Tied to Child Behavioral ProblemsTalk Therapy May Be Worth It for Teen DepressionCognitive Behavioral Therapy Cost-Effective in Depressed TeensWomen Seem More Prone to Winter BluesTransdermal Estradiol May Help Prevent Depressive SymptomsHormone Therapy May Ease Depression Linked to MenopauseEsketamine Safe, Effective for Treatment-Resistant DepressionDermatologists Often Undervalue Depression, Anxiety in Patients
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Bipolar Disorder
Addictions: Alcohol and Substance Abuse
Pain Management

Locus ID'd That Links Comorbid Alcohol Dependence, Depression

HealthDay News
Updated: Oct 26th 2017

new article illustration

THURSDAY, Oct. 26, 2017 (HealthDay News) -- A newly identified genetic risk variant is associated with comorbid alcohol dependence (AD) and major depression (MD) in African Americans, according to a study published online Oct. 25 in JAMA Psychiatry.

Hang Zhou, Ph.D., from Yale University School of Medicine in New Haven, Connecticut, and colleagues conducted a genome-wide association study that analyzed criterion counts of comorbid AD and MD in African American and European American data sets. The study was performed in two samples (Yale-Penn 1 and Yale-Penn 2) with 4,653 African American participants and 3,169 European American participants.

The researchers found that the median comorbid criterion count was 6.2. There was a significant association for rs139438618 at the semaphorin 3A (SEMA3A) locus with AD and MD comorbidity in African American participants in the Yale-Penn 1 sample (β = 0.89) and the Yale-Penn 2 sample (β = 0.83). A more robust association was yielded in meta-analysis of the two samples (β = 0.87). No significant correlation was seen in European American participants. Individuals with higher risk of neuroticism or depressive symptoms, and a lower level of subjective well-being and educational attainment had a higher level of AD and MD comorbidity in analyses of polygenic risk scores. Higher risks of AD and MD comorbidity were seen for larger intracranial and smaller putamen volumes.

"SEMA3A variation is significantly and replicably associated with comorbid AD and MD in African American participants," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)